Literature DB >> 26206252

Control of Apoptosis in Treatment and Biology of Pancreatic Cancer.

Shrey Modi1, Devika Kir1, Sulagna Banerjee1, Ashok Saluja1.   

Abstract

Pancreatic cancer is estimated to be the 12th most common cancer in the United States in 2014 and yet this malignancy is the fourth leading cause of cancer-related death in the United States. Late detection and resistance to therapy are the major causes for its dismal prognosis. Apoptosis is an actively orchestrated cell death mechanism that serves to maintain tissue homoeostasis. Cancer develops from normal cells by accruing significant changes through one or more mechanisms, leading to DNA damage and mutations, which in a normal cell would induce this programmed cell death pathway. As a result, evasion of apoptosis is one of the hallmarks of cancer cells. PDAC is notoriously resistant to apoptosis, thereby explaining its aggressive nature and resistance to conventional treatment modalities. The current review is focus on understanding different intrinsic and extrinsic pathways in pancreatic cancer that may affect apoptosis in this disease.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  APOPTOSIS; PANCREATIC CANCER; SIGNALLING; THERAPY

Mesh:

Substances:

Year:  2016        PMID: 26206252      PMCID: PMC5724757          DOI: 10.1002/jcb.25284

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  89 in total

Review 1.  Targeting apoptosis pathways in pancreatic cancer.

Authors:  Alexander Arlt; Susanne Sebens Müerköster; Heiner Schäfer
Journal:  Cancer Lett       Date:  2010-11-13       Impact factor: 8.679

2.  Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancer.

Authors:  Lillian L Siu; Ahmad Awada; Chris H Takimoto; Martine Piccart; Brian Schwartz; Tom Giannaris; Chetan Lathia; Oana Petrenciuc; Malcolm J Moore
Journal:  Clin Cancer Res       Date:  2006-01-01       Impact factor: 12.531

3.  Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis.

Authors:  Florian R Greten; Christoph K Weber; Tim F Greten; Günter Schneider; Martin Wagner; Guido Adler; Roland M Schmid
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

Review 4.  Advanced or metastatic pancreatic cancer: molecular targeted therapies.

Authors:  Soley Bayraktar; Caio M Rocha-Lima
Journal:  Mt Sinai J Med       Date:  2010 Nov-Dec

5.  Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy.

Authors:  Rita Bayer Lopes; Rathi Gangeswaran; Iain A McNeish; Yaohe Wang; Nick R Lemoine
Journal:  Int J Cancer       Date:  2007-06-01       Impact factor: 7.396

6.  Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas.

Authors:  Meritxell Rovira; Sherri-Gae Scott; Andrew S Liss; Jan Jensen; Sarah P Thayer; Steven D Leach
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

7.  The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.

Authors:  Qiang G Dong; Guido M Sclabas; Shuichi Fujioka; Christian Schmidt; Bailu Peng; TianAi Wu; Ming-Sound Tsao; Douglas B Evans; James L Abbruzzese; Timothy J McDonnell; Paul J Chiao
Journal:  Oncogene       Date:  2002-09-19       Impact factor: 9.867

8.  Sonic hedgehog promotes desmoplasia in pancreatic cancer.

Authors:  Jennifer M Bailey; Benjamin J Swanson; Tomofumi Hamada; John P Eggers; Pankaj K Singh; Thomas Caffery; Michel M Ouellette; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

Review 9.  Apoptosis in cancer--implications for therapy.

Authors:  Henning Schulze-Bergkamen; Peter H Krammer
Journal:  Semin Oncol       Date:  2004-02       Impact factor: 4.929

10.  Triptolide activates unfolded protein response leading to chronic ER stress in pancreatic cancer cells.

Authors:  Nameeta Mujumdar; Sulagna Banerjee; Zhiyu Chen; Veena Sangwan; Rohit Chugh; Vikas Dudeja; Masato Yamamoto; Selwyn M Vickers; Ashok K Saluja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-03       Impact factor: 4.052

View more
  14 in total

Review 1.  Novel therapeutic strategies and perspectives for pancreatic cancer: Autophagy and apoptosis are key mechanisms to fight pancreatic cancer.

Authors:  Wenhao Luo; Lianfang Zheng; Taiping Tai Zhang
Journal:  Med Oncol       Date:  2021-05-21       Impact factor: 3.064

2.  MAGED4B Promotes Glioma Progression via Inactivation of the TNF-α-induced Apoptotic Pathway by Down-regulating TRIM27 Expression.

Authors:  Can Liu; Jun Liu; Juntang Shao; Cheng Huang; Xingliang Dai; Yujun Shen; Weishu Hou; Yuxian Shen; Yongqiang Yu
Journal:  Neurosci Bull       Date:  2022-08-20       Impact factor: 5.271

3.  Honokiol Suppressed Pancreatic Cancer Progression via miR-101/Mcl-1 Axis.

Authors:  Yishuo Wang; Zhongyong Liu; Qinrong Liu; Yongguang Han; Yuncai Zang; Huichao Zhang; Xuzhao Du; Tao Qin; Yuquan Wu
Journal:  Cancer Manag Res       Date:  2020-07-01       Impact factor: 3.989

4.  The effects of HIF-1α overexpression on renal injury, immune disorders and mitochondrial apoptotic pathways in renal ischemia/reperfusion rats.

Authors:  Xiaoli Li; Wenhui Chen; Jinfang Feng; Bo Zhao
Journal:  Transl Androl Urol       Date:  2020-10

Review 5.  Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance.

Authors:  Monish Ram Makena; Himavanth Gatla; Dattesh Verlekar; Sahithi Sukhavasi; Manoj K Pandey; Kartick C Pramanik
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

Review 6.  The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance.

Authors:  Kalyani Patil; Farheen B Khan; Sabah Akhtar; Aamir Ahmad; Shahab Uddin
Journal:  Cancer Metastasis Rev       Date:  2021-08-28       Impact factor: 9.264

7.  Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer.

Authors:  Xuhui Fan; Haotian Fu; Ni Xie; Hangcheng Guo; Tiantian Fu; Yunfeng Shan
Journal:  Aging (Albany NY)       Date:  2021-10-08       Impact factor: 5.682

Review 8.  The Implications for Cells of the Lipid Switches Driven by Protein-Membrane Interactions and the Development of Membrane Lipid Therapy.

Authors:  Manuel Torres; Catalina Ana Rosselló; Paula Fernández-García; Victoria Lladó; Or Kakhlon; Pablo Vicente Escribá
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

9.  Plasma Membrane Ca2+ ATPase Isoform 4 (PMCA4) Has an Important Role in Numerous Hallmarks of Pancreatic Cancer.

Authors:  Pishyaporn Sritangos; Eduardo Pena Alarcon; Andrew D James; Ahlam Sultan; Daniel A Richardson; Jason I E Bruce
Journal:  Cancers (Basel)       Date:  2020-01-16       Impact factor: 6.639

Review 10.  Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics.

Authors:  Neerada Meenakshi Warrier; Prasoon Agarwal; Praveen Kumar
Journal:  Stem Cell Rev Rep       Date:  2020-10       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.